Warren Buffett fit · De grandes entreprises à un prix juste
Is Gyre Therapeutics, Inc. Common Stock (GYRE) a Warren Buffett Stock?
Low Buffett fit — meets only 3/9 criteria; valuation, moat, or financial health flags risk.
20/100
FPas un fit
3/9 critères validés
Les critères de Warren Buffett, appliqués à GYRE
ROIC ≥ 15%
clé11.7%
Gross margin ≥ 40%
clé95.5%
Owner earnings yield ≥ 5%
clé1.2%
5y profitable
clé
Comment GYRE se classe selon d'autres stratégies
Données financières en direct
Cap. boursière
$731.67M
PER (TTM)
55.7x
ROIC (TTM)
11.69%
Marge brute
95.48%
Questions fréquentes
What is GYRE's Warren Buffett fit score?
GYRE scores 20/100 on our Warren Buffett fit engine — grade F. Low Buffett fit — meets only 3/9 criteria; valuation, moat, or financial health flags risk.
Does Warren Buffett actually own GYRE?
Our score is computed from financial fundamentals against Warren Buffett's published criteria. We don't claim that Warren Buffett personally owns or recommends GYRE.
How often is this score updated?
GYRE's Warren Buffett fit score is recomputed daily from the latest TTM financials.
Outil éducatif, pas un conseil en investissement. Les scores sont calculés à partir de données financières publiques selon les critères publiés de chaque stratégie d'investissement. Nous ne prétendons pas que Warren Buffett possède ou recommande GYRE personnellement.